newsfilter
← Latest News
PR Newswire·

Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine

SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP) is currently completing a strategic analysis of its next 5 years of growth. As part of this analysis, diversifying beyond therapeutics into in-vitro diagnostics